We are live on ! Find out more
SXTPW icon

60 Degrees Pharmaceuticals Warrant

5 hedge funds and large institutions have $12.2K invested in 60 Degrees Pharmaceuticals Warrant in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% less funds holding

Funds holding: 85 (-3)

50% less capital invested

Capital invested by funds: $24.4K → $12.2K (-$12.2K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
1
Walleye Capital
New York
$6.05K
CS
2
Clear Street
New York
$4.41K
TC
3
Torno Capital
Massachusetts
$1.43K
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$329 -$342 -7,271 -40%
UBS Group
5
UBS Group
Switzerland
$20 -$3 -55 -8%
Mariner
6
Mariner
Kansas
-$2K -39,997 Closed
TSS
7
Two Sigma Securities
New York
-$1.14K -22,693 Closed
Citadel Advisors
8
Citadel Advisors
Florida
-$621 -12,400 Closed

SXTPW Hedge Fund Activity: Q2 2026 in Review

5 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q2 2026, worth a combined $12.2K — down 50% from $24.4K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SXTPW and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Mariner, exiting entirely with an estimated $2K sold.

  • 5 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q2 2026, down from 8 in Q1 2026.
  • Funds reported $12.2K of 60 Degrees Pharmaceuticals Warrant stock for Q2 2026, down 50% quarter-over-quarter.
  • 0 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q2 2026 and 3 closed out, a net change of -3 holders.
  • The largest 60 Degrees Pharmaceuticals Warrant seller in Q2 2026 was Mariner, an estimated $2K sold.

Based on aggregated 13F filings for Q2 2026.